{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:45:46Z","timestamp":1772991946164,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.humpath.2019.08.016","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T20:15:12Z","timestamp":1566504912000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Clinicopathologic study of deciduoid mesothelioma using SMARCB1\/INI1 immunohistochemistry and fluorescence in situ hybridization"],"prefix":"10.1016","volume":"93","author":[{"given":"Toshiaki","family":"Kawai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2019.08.016_bb0005","series-title":"WHO classification of Tumours of the Lung, Pleura, Thymus and Heart","first-page":"154","article-title":"WHO classification of tumours of the pleura","author":"Galateau-Salle","year":"2015"},{"key":"10.1016\/j.humpath.2019.08.016_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00000478-198501000-00012","article-title":"Diffuse malignant peritoneal mesothelioma in a 13-year-old girl: report of a case and review of the literature","volume":"9","author":"Talerman","year":"1985","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0015","first-page":"439","article-title":"Deciduoid peritoneal mesothelioma","volume":"18","author":"Nascimento","year":"1994","journal-title":"An unusual phenotype affecting young females. Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0020","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/modpathol.2012.105","article-title":"Deciduoid mesothelioma: report of 21 cases with review of the literature","volume":"25","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/modpathol.3800543","article-title":"Mesothelioma with rhabdoid features: an ultrastructural and immunohistochemical study of 10 cases","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc1273","article-title":"The SW1\/SNF complex-chromatin and cancer","volume":"4","author":"Roberts","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2019.08.016_bb0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ccr.2005.04.001","article-title":"Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability","volume":"7","author":"Imbalzano","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2019.08.016_bb0040","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/modpathol.2008.44","article-title":"Renal medullay carcinoma: rhabdoid features and the absence of INI1 expression as markers as markers of aggressive behavior","volume":"21","author":"Cheng","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.humpath.2008.08.007","article-title":"Infrequent SMARCB1\/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor","volume":"40","author":"Kohashi","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0050","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e318161781a","article-title":"SMARCB1\/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1\/INI1 negative variant extraskeletal myxoid chondrosarcoma","volume":"32","author":"Kohashi","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0055","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/modpathol.2010.71","article-title":"Reduced expression of SMARCB1\/INI1\u202fprotein in\u202fsynovial sarcoma","volume":"23","author":"Kohashi","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0060","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/PAS.0b013e318224d2cd","article-title":"Malignant\u202frhabdoid\u202ftumors express stem cell factors, which relate to the expression of\u202fEZH2\u202fand Id proteins","volume":"35","author":"Venneti","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0065","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0b013e31822b325b","article-title":"INI1-deficient tumors: diagnostic features and molecular genetics","volume":"35","author":"Hollmann","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0070","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/pin.12623","article-title":"SMARCB1\/INI1\/BAF47- deficient pleural malignant mesothelioma with rhabdoid features","volume":"68","author":"Kimura","year":"2018","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2019.08.016_bb0075","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jclinpath-2015-203211","article-title":"Peritoneal maligmant mesothelioma\u202f(PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses","volume":"69","author":"Kawai","year":"2016","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/modpathol.2015.121","article-title":"The prognostic significance of BAP-1, NF2, and CDKN2A in malignant peritoneal mesothelioma","volume":"29","author":"Singhi","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0085","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/PAS.0000000000000616","article-title":"et. al. BAP1 immunohistochemistry and p16 in the diagnosis of sarcomatous and desmoplastic mesotheliomas","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPT94JVWIHBKRD","article-title":"Diagnostic usefulness of p16\/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis","volume":"139","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0095","first-page":"89","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma","volume":"142","author":"Husain","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2019.08.016_bb0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0105","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2019.08.016_bb0110","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/onc.2009.4","article-title":"The SWI\/SNF complex and cancer","volume":"28","author":"Reisman","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2019.08.016_bb0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/366170a0","article-title":"BRG1\u202fcontains a conserved domain of the SWI2\/SNF2 family necessary for normal mitotic growth and transcription","volume":"366","author":"Khavari","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2019.08.016_bb0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0960-9822(01)00090-2","article-title":"Chromatin remodeling enzymes: who's on first?","volume":"11","author":"Fry","year":"2001","journal-title":"Curr Biol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0125","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1101\/gad.10.17.2117","article-title":"Diversity and specialization of mammalian\u202fSWI\/SNF\u202fcomplexes","volume":"10","author":"Wang","year":"1996","journal-title":"Genes Dev"},{"key":"10.1016\/j.humpath.2019.08.016_bb0130","first-page":"560","article-title":"Loss of BRG1\/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis","volume":"63","author":"Reisman","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2019.08.016_bb0135","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1158\/1078-0432.CCR-03-0489","article-title":"Chromatin remodeling factors and BRM\/BRG1\u202fexpression as prognostic indicators in non-small cell lung cancer","volume":"10","author":"Fukuoka","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2019.08.016_bb0140","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/humu.20730","article-title":"Frequent BRG1\/SMARCA4-inactivating mutations in human lung cancer cell lines","volume":"29","author":"Medina","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.humpath.2019.08.016_bb0145","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1158\/0008-5472.CAN-14-0061","article-title":"BRG1\/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization","volume":"74","author":"Orvis","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2019.08.016_bb0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-017-2148-5","article-title":"SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg\/CK7pos\/HepPar-1pos immunophenotype","volume":"471","author":"Agaimy","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2019.08.016_bb0155","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/modpathol.2017.11","article-title":"Clinicopathological and molecular molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities","volume":"30","author":"Yoshida","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0160","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/modpathol.2017.61","article-title":"SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior","volume":"30","author":"Sauter","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0165","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1038\/sj.onc.1205841","article-title":"A key role of the hSNF5\/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle","volume":"21","author":"Versteege","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2019.08.016_bb0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.humpath.2016.04.018","article-title":"Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency","volume":"55","author":"Wang","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2019.08.016_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3835(00)00342-6","article-title":"Absence of hSNF5\/INI1 mutation in human lung cancer","volume":"153","author":"Manda","year":"2000","journal-title":"Cancer Lett"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719301558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719301558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:35:46Z","timestamp":1758645346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817719301558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":35,"alternative-id":["S0046817719301558"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2019.08.016","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic study of deciduoid mesothelioma using SMARCB1\/INI1 immunohistochemistry and fluorescence in situ hybridization","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2019.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}